The Blood Alliance has merged with OneBlood
The Blood Alliance (TBA) has merged with OneBlood. Financial details have not been disclosed.
The Blood Alliance is a non-profit community bloodcenter that provides blood to more than 30 hospitals and medical facilities in Florida, Georgia, and South Carolina. It provides a safe and adequate blood supply to the regions it serves and is a member of America’s Blood Centers – a national network of independent community blood centers responsible for nearly half of the nation’s blood supply. TBA has been enriching lives since 1942 and is licensed by the FDA and accredited by the AABB.
Based in Orlando, Florida, OneBlood, which was formed as the result of a merger of three blood banks in 2012, is a community blood bank serving the Tampa Bay area, south and southeast Florida, the Orlando metropolitan area and surrounding central Florida counties, parts of southwest Florida, Pensacola and Tallahassee and some parts of southern Georgia and Alabama.
Oaklins' team in Jacksonville acted as intermediary and financial advisor to The Blood Alliance in this transaction.
Talk to the deal team
Related deals
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn moreAfric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more